TCL Archive In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30 September 20, 1974
TCL Archive DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year December 14, 1979
TCL Archive Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level” November 12, 2010
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
